Rapidly progressive endomyocardial fibrosis and heart failure in a 17-year-old female with limited cutaneous systemic sclerosis

Scand J Rheumatol. 2019 Jul;48(4):336-337. doi: 10.1080/03009742.2018.1550211. Epub 2019 Jan 22.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Disease Progression
  • Echocardiography / methods
  • Endomyocardial Fibrosis* / diagnosis
  • Endomyocardial Fibrosis* / drug therapy
  • Endomyocardial Fibrosis* / etiology
  • Endomyocardial Fibrosis* / physiopathology
  • Female
  • Heart Failure* / diagnosis
  • Heart Failure* / drug therapy
  • Heart Failure* / etiology
  • Heart Failure* / physiopathology
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Pericardial Effusion / diagnosis
  • Pericardial Effusion / etiology
  • Prognosis
  • Scleroderma, Limited* / complications
  • Scleroderma, Limited* / diagnosis
  • Scleroderma, Limited* / physiopathology
  • Severity of Illness Index
  • Tomography, X-Ray Computed / methods

Substances

  • Immunosuppressive Agents